• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

December 4, 2009 FDA/Industry Working Group (IWG) Public Meeting on Risk Evaluation and Mitigation Strategies (REMS) for Certain Opioids

On December 4, 2009, FDA held a public meeting with sponsors of certain opioid drug products regarding the opioid REMS.  FDA has encouraged affected sponsors to work collectively to develop a proposed REMS.  The purpose of this meeting was to hear from sponsors about the status of the development of a proposed REMS and their views regarding the specific features of the REMS.  

-

Additional Information

-